• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期大量饮酒、营养状况及肝损伤进展对酒精性肝炎患者的死亡风险产生负面影响。

Chronic and Heavy Drinking, Nutrition Status, and Progression of Liver Injury Negatively Affect the Mortality Risk in Patients Suffering from Alcohol-Associated Hepatitis.

作者信息

Thakurdesai Aishwarya, Kumari Anjali, Shay Henry, Elgharabawy Khaled, Winrich Evan J, Zhang Wanyu, Jackson Amber, Cave Matthew C, Kong Maiying, Zhang Xiang, Singal Ashwani K, McClain Craig J, Vatsalya Vatsalya

机构信息

Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Louisville, Louisville, KY 40202, USA.

Clinical Laboratory for the Intervention Development of AUD and Organ Severity, Louisville, KY 40202, USA.

出版信息

J Clin Med. 2025 Aug 31;14(17):6157. doi: 10.3390/jcm14176157.

DOI:10.3390/jcm14176157
PMID:40943916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12429474/
Abstract

: Alcohol-associated hepatitis (AH) is an acute inflammatory condition of alcohol-associated liver disease (ALD) with rapid progression and high mortality. The Age-Bilirubin-INR-Creatinine (ABIC) score is a static algorithm that predicts survivability in AH. The roles of alcohol drinking patterns and nutritional status in AH progression and risk of death are understudied. This study evaluates the impact of alcohol drinking patterns and nutrition on AH progression and mortality. : Sixty-one adult patients diagnosed with AH were stratified by the Model for End-Stage Liver Disease (MELD) as non-severe (MELD < 20, = 26, Gr.1) and severe (MELD ≥ 20, = 35, Gr.2). Each group was further subdivided by ABIC: low- (<6.71), intermediate- (6.71-9), and high- (>9) risk categories. We assessed different demographics: nutrition using the Controlling Nutritional Status (CONUT) score; lifetime drinking history (LTDH); recent alcohol use (AUDIT); laboratory measures (complete metabolic panel, complete blood count, and coagulation), and clinical measures (Maddrey DF, Child-Turcotte-Pugh, and Lille). : All patients showed a significant and positive correlation between ABIC and LTDH (r = 0.538, = 0.004), particularly in Gr.2 (r = 0.554, = 0.011). The low-risk Gr.2 exhibited the highest AST:ALTs. AST:ALTs were significantly associated with LTDH, AUDIT, and CONUT (R = 0.539, = 0.031). In all AH patients with intermediate mortality risk, AST:ALTs were strongly linked to CONUT and LTDH (R = 0.657, = 0.017). : Severe AH demonstrates rapid liver injury progression even when the mortality risk is low. Chronic and recent heavy alcohol consumption and poor nutrition adversely impact AH severity and mortality risk. Alcohol intake and nutritional assessments in routine clinicals could identify high-risk patients, thereby improving treatment and a favorable prognosis.

摘要

酒精性肝炎(AH)是酒精性肝病(ALD)的一种急性炎症状态,进展迅速且死亡率高。年龄-胆红素-INR-肌酐(ABIC)评分是一种预测AH患者生存能力的静态算法。饮酒模式和营养状况在AH进展及死亡风险中的作用尚未得到充分研究。本研究评估饮酒模式和营养对AH进展及死亡率的影响。61例诊断为AH的成年患者根据终末期肝病模型(MELD)分为非重度(MELD<20,n = 26,第1组)和重度(MELD≥20,n = 35,第2组)。每组再根据ABIC进一步细分:低风险(<6.71)、中度风险(6.71 - 9)和高风险(>9)类别。我们评估了不同的人口统计学特征:使用控制营养状况(CONUT)评分评估营养状况;终生饮酒史(LTDH);近期饮酒情况(AUDIT);实验室检查指标(全代谢组、全血细胞计数和凝血功能)以及临床指标(Maddrey DF、Child-Turcotte-Pugh和Lille评分)。所有患者的ABIC与LTDH之间均呈显著正相关(r = 0.538,p = 0.004),尤其是在第2组(r = 0.554,p = 0.011)。低风险的第2组患者AST:ALT比值最高。AST:ALT比值与LTDH、AUDIT和CONUT显著相关(R = 0.539,p = 0.03)。在所有中度死亡风险的AH患者中,AST:ALT比值与CONUT和LTDH密切相关(R = 0.657,p = 0.017)。重度AH即使在死亡风险较低时也显示出快速的肝损伤进展。长期和近期大量饮酒以及营养不良会对AH的严重程度和死亡风险产生不利影响。在常规临床中进行酒精摄入量和营养评估可以识别高危患者,从而改善治疗效果并获得良好预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12429474/0d26fe1fc2f0/jcm-14-06157-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12429474/c9748a3527a8/jcm-14-06157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12429474/047b00749385/jcm-14-06157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12429474/e4cb9d01cf56/jcm-14-06157-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12429474/0d26fe1fc2f0/jcm-14-06157-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12429474/c9748a3527a8/jcm-14-06157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12429474/047b00749385/jcm-14-06157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12429474/e4cb9d01cf56/jcm-14-06157-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12429474/0d26fe1fc2f0/jcm-14-06157-g004.jpg

相似文献

1
Chronic and Heavy Drinking, Nutrition Status, and Progression of Liver Injury Negatively Affect the Mortality Risk in Patients Suffering from Alcohol-Associated Hepatitis.长期大量饮酒、营养状况及肝损伤进展对酒精性肝炎患者的死亡风险产生负面影响。
J Clin Med. 2025 Aug 31;14(17):6157. doi: 10.3390/jcm14176157.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
4
Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.疑似酒精性肝病患者肝纤维化无创诊断评估工具的系统评价和经济评估。
Health Technol Assess. 2012;16(4):1-174. doi: 10.3310/hta16040.
5
Nutritional support for liver disease.肝病的营养支持
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008344. doi: 10.1002/14651858.CD008344.pub2.
6
GDF15 is associated with hepatocellular senescence and correlates with mortality in patients with alcohol-associated hepatitis.生长分化因子15与肝细胞衰老相关,并与酒精性肝炎患者的死亡率相关。
JHEP Rep. 2025 Jun 10;7(9):101478. doi: 10.1016/j.jhepr.2025.101478. eCollection 2025 Sep.
7
The gut-immune-liver axis in patients with alcohol use disorder and clinically low serum zinc levels.酒精使用障碍且临床血清锌水平低的患者的肠道-免疫-肝脏轴
Alcohol Clin Exp Res (Hoboken). 2024 Sep;48(9):1740-1752. doi: 10.1111/acer.15408. Epub 2024 Aug 2.
8
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.
9
ACG Clinical Guideline: Alcohol-Associated Liver Disease.ACG 临床指南:酒精相关性肝病。
Am J Gastroenterol. 2024 Jan 1;119(1):30-54. doi: 10.14309/ajg.0000000000002572. Epub 2023 Sep 1.
10
COVID-19 pandemic stressors are associated with reported increases in frequency of drunkenness among individuals with a history of alcohol use disorder.新冠疫情压力源与有酒精使用障碍病史的个体醉酒频率增加的报告有关。
Transl Psychiatry. 2023 Oct 6;13(1):311. doi: 10.1038/s41398-023-02577-1.

本文引用的文献

1
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective.酒精使用障碍的管理:以胃肠病学和肝病学为重点的视角
Lancet Gastroenterol Hepatol. 2025 May;10(5):475-490. doi: 10.1016/S2468-1253(24)00380-7. Epub 2025 Feb 13.
2
Early detection of liver disease in patients with alcohol use disorder improves long-term abstinence.早期发现酒精使用障碍患者的肝病可提高长期戒酒率。
Alcohol Alcohol. 2024 Sep 21;59(6). doi: 10.1093/alcalc/agae074.
3
Survival and Disease Progression in Older Adult Patients With Cirrhosis: A Retrospective Study.
老年肝硬化患者的生存与疾病进展:一项回顾性研究
Int J Hepatol. 2024 Aug 8;2024:5852680. doi: 10.1155/2024/5852680. eCollection 2024.
4
The gut-immune-liver axis in patients with alcohol use disorder and clinically low serum zinc levels.酒精使用障碍且临床血清锌水平低的患者的肠道-免疫-肝脏轴
Alcohol Clin Exp Res (Hoboken). 2024 Sep;48(9):1740-1752. doi: 10.1111/acer.15408. Epub 2024 Aug 2.
5
Utility of Lille Score in Predicting 30-Day Survival in Steroid-Treated Alcohol-Associated Hepatitis.利尔评分预测激素治疗酒精相关性肝炎 30 天生存率的效用。
Dig Dis Sci. 2024 Aug;69(8):3043-3050. doi: 10.1007/s10620-024-08479-6. Epub 2024 Jun 18.
6
Alcohol-associated liver disease.酒精相关性肝病。
J Clin Invest. 2024 Feb 1;134(3):e176345. doi: 10.1172/JCI176345.
7
One-month assessment of Th-cell axis related inflammatory cytokines, IL-17 and IL-22 and their role in alcohol-associated liver disease.酒精相关性肝病中 Th 细胞轴相关炎症细胞因子 IL-17 和 IL-22 及其作用的一个月评估。
Front Immunol. 2023 Dec 14;14:1202267. doi: 10.3389/fimmu.2023.1202267. eCollection 2023.
8
Prognostic models in alcohol-related liver disease and alcohol-related hepatitis.酒精性肝病和酒精性肝炎的预后模型。
Best Pract Res Clin Gastroenterol. 2023 Dec;67:101867. doi: 10.1016/j.bpg.2023.101867. Epub 2023 Sep 11.
9
Advances in the understanding and management of alcohol-related liver disease.酒精性肝病的认识和管理进展。
BMJ. 2023 Nov 20;383:e077090. doi: 10.1136/bmj-2023-077090.
10
Management of alcoholic hepatitis: A clinical perspective.酒精性肝炎的治疗:临床视角。
Liver Int. 2023 Oct;43(10):2078-2095. doi: 10.1111/liv.15701. Epub 2023 Aug 22.